Pertussis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Pertussis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Pertussis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pertussis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pertussis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pertussis secondary prevention
CDC onPertussis secondary prevention
Pertussis secondary prevention in the news
Blogs on Pertussis secondary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Pertussis secondary prevention

Secondary Prevention

Post exposure prophylaxis

• Postexposure antibiotic prophylaxis is needed for individuals with close contact to a person with pertussis.
• Administration of postexposure therapy to asymptomatic contacts of index patient within 21 days of onset of cough can prevent symptomatic infection.